Atara Biotherapeutics Stock Market Value
| ATRA Stock | USD 12.12 0.65 5.67% |
| Symbol | Atara |
Atara Biotherapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atara Biotherapeutics. If investors know Atara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atara Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (25.32) | Revenue Per Share 12.263 | Quarterly Revenue Growth 28.927 | Return On Assets (0.57) | Return On Equity (20.15) |
The market value of Atara Biotherapeutics is measured differently than its book value, which is the value of Atara that is recorded on the company's balance sheet. Investors also form their own opinion of Atara Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Atara Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atara Biotherapeutics' market value can be influenced by many factors that don't directly affect Atara Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atara Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Atara Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atara Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Atara Biotherapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Atara Biotherapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Atara Biotherapeutics.
| 01/06/2023 |
| 11/26/2024 |
If you would invest 0.00 in Atara Biotherapeutics on January 6, 2023 and sell it all today you would earn a total of 0.00 from holding Atara Biotherapeutics or generate 0.0% return on investment in Atara Biotherapeutics over 690 days. Atara Biotherapeutics is related to or competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer... More
Atara Biotherapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Atara Biotherapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Atara Biotherapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.42 | |||
| Information Ratio | 0.1217 | |||
| Maximum Drawdown | 44.5 | |||
| Value At Risk | (10.39) | |||
| Potential Upside | 19.77 |
Atara Biotherapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Atara Biotherapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Atara Biotherapeutics' standard deviation. In reality, there are many statistical measures that can use Atara Biotherapeutics historical prices to predict the future Atara Biotherapeutics' volatility.| Risk Adjusted Performance | 0.1145 | |||
| Jensen Alpha | 0.8805 | |||
| Total Risk Alpha | (0.15) | |||
| Sortino Ratio | 0.1772 | |||
| Treynor Ratio | 0.6452 |
Atara Biotherapeutics Backtested Returns
Atara Biotherapeutics is slightly risky given 3 months investment horizon. Atara Biotherapeutics secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had a 0.15% return per unit of standard deviation over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.18% are justified by taking the suggested risk. Use Atara Biotherapeutics mean deviation of 5.41, and Risk Adjusted Performance of 0.1145 to evaluate company specific risk that cannot be diversified away. Atara Biotherapeutics holds a performance score of 11 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.67, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Atara Biotherapeutics will likely underperform. Use Atara Biotherapeutics sortino ratio, semi variance, and the relationship between the standard deviation and value at risk , to analyze future returns on Atara Biotherapeutics.
Auto-correlation | 0.60 |
Good predictability
Atara Biotherapeutics has good predictability. Overlapping area represents the amount of predictability between Atara Biotherapeutics time series from 6th of January 2023 to 17th of December 2023 and 17th of December 2023 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Atara Biotherapeutics price movement. The serial correlation of 0.6 indicates that roughly 60.0% of current Atara Biotherapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.6 | |
| Spearman Rank Test | 0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 21.02 |
Atara Biotherapeutics lagged returns against current returns
Autocorrelation, which is Atara Biotherapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Atara Biotherapeutics' stock expected returns. We can calculate the autocorrelation of Atara Biotherapeutics returns to help us make a trade decision. For example, suppose you find that Atara Biotherapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Atara Biotherapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Atara Biotherapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Atara Biotherapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Atara Biotherapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Atara Biotherapeutics Lagged Returns
When evaluating Atara Biotherapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Atara Biotherapeutics stock have on its future price. Atara Biotherapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Atara Biotherapeutics autocorrelation shows the relationship between Atara Biotherapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Atara Biotherapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Atara Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Atara Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atara Biotherapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atara Biotherapeutics Stock:Check out Atara Biotherapeutics Correlation, Atara Biotherapeutics Volatility and Atara Biotherapeutics Alpha and Beta module to complement your research on Atara Biotherapeutics. For information on how to trade Atara Stock refer to our How to Trade Atara Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Atara Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.